Exact Mass: 609.1859542000001
Exact Mass Matches: 609.1859542000001
Found 92 metabolites which its exact mass value is equals to given mass value 609.1859542000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Peonidin 3-rhamnoside 5-glucoside
Peonidin 3-rhamnoside 5-glucoside is found in common pea. Peonidin 3-rhamnoside 5-glucoside is isolated from peas. Isolated from peas. Peonidin 3-rhamnoside 5-glucoside is found in pulses and common pea.
Malvidin 3-glucoside-4-vinylphenol
Malvidin 3-glucoside-4-vinylphenol is found in alcoholic beverages. Malvidin 3-glucoside-4-vinylphenol is a pigment isolated from red wine made from grapes (Vitis vinifera Pigment isolated from red wine made from grapes (Vitis vinifera). Malvidin 3-glucoside-4-vinylphenol is found in grape wine, alcoholic beverages, and common grape.
3-Ferulylpelargonidin 5-glucoside
3-Ferulylpelargonidin 5-glucoside is found in root vegetables. 3-Ferulylpelargonidin 5-glucoside is isolated from red radish (Raphanus sp.). Isolated from red radish (Raphanus species). 3-Ferulylpelargonidin 5-glucoside is found in root vegetables.
Isopeonidin 3-rutinoside
Isopeonidin 3-rutinoside is a polyphenol metabolite detected in biological fluids (PMID: 20428313). A polyphenol metabolite detected in biological fluids [PhenolExplorer]
Peonidin 3-(6'-p-coumaroyl-glucoside)
Peonidin 3-(6-p-coumaroyl-glucoside) is a member of the class of compounds known as anthocyanidin 3-o-6-p-coumaroyl glycosides. Anthocyanidin 3-o-6-p-coumaroyl glycosides are anthocyanidin 3-O-glycosides where the carbohydrate moiety is esterified at the C6 position with a p-coumaric acid. P-coumaric acid is an organic derivative of cinnamic acid, that carries a hydroxyl group at the 4-position of the benzene ring. Peonidin 3-(6-p-coumaroyl-glucoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-p-coumaroyl-glucoside) can be found in common grape and grape wine, which makes peonidin 3-(6-p-coumaroyl-glucoside) a potential biomarker for the consumption of these food products.
Peonidin 3-rutinoside
Peonidin 3-rutinoside is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-rutinoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-rutinoside can be found in a number of food items such as european plum, blackcurrant, lima bean, and french plantain, which makes peonidin 3-rutinoside a potential biomarker for the consumption of these food products.
kaempferol 3-O-beta-D-glucosyl-(1->2)-glucoside
Kaempferol 3-o-beta-d-glucosyl-(1->2)-glucoside is also known as kaempferol-3-O-sophoroside. Kaempferol 3-o-beta-d-glucosyl-(1->2)-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Kaempferol 3-o-beta-d-glucosyl-(1->2)-glucoside can be found in a number of food items such as macadamia nut, abalone, savoy cabbage, and sago palm, which makes kaempferol 3-o-beta-d-glucosyl-(1->2)-glucoside a potential biomarker for the consumption of these food products. Kaempferol 3-o-β-d-glucosyl-(1->2)-glucoside is also known as kaempferol-3-O-sophoroside. Kaempferol 3-o-β-d-glucosyl-(1->2)-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Kaempferol 3-o-β-d-glucosyl-(1->2)-glucoside can be found in a number of food items such as macadamia nut, abalone, savoy cabbage, and sago palm, which makes kaempferol 3-o-β-d-glucosyl-(1->2)-glucoside a potential biomarker for the consumption of these food products.
Peonidin 3-(6-p-coumarylglucoside)
(2R,3R,4R,5S)-2-(6-amino-9H-purin-9-yl)-4-{[(E)-3-(1H-imidazol-4-yl)-2-propenoyl]oxy}-5-[(methylsulfinyl)methyl]tetrahydro-3-furanyl(Z)-3-(4-hydroxyphenyl)-2-methoxy-2-propenoate
3-Ferulylpelargonidin 5-glucoside
Peonidin 3-rhamnoside 5-glucoside
Isopeonidin 3-rutinoside
FM 1-43 dye
C30H49Br2N3 (609.2292994000001)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
RO 46-8443
C31H35N3O8S (609.2144750000001)
Ro 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. Ro 46-8443 displays an at least 100-fold selectivity for ETB (IC50: 34-69 nM) over ETA receptors (IC50: 6800 nM)[1][2].
(2R,3S)-2-(1R)-1-(3,5-BIS(TRIFLUROMETHYL)PHENYL) ETHOXY)-3-( 4-FLUOROPHENYL) MORPHOLINE 4-METHYLBENZENESULFONATE
C27H26F7NO5S (609.1419830000001)
alpha-L-Fucp-(1->4)-[beta-D-Galp3S-(1->3)]-beta-D-GlcpNAc
C20H35NO18S (609.1574770000001)
peonidin-3-O-(6-O-trans-p-coumaryl-beta-D-glucoside)
3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate
beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-6-O-sulfo-beta-D-glucosamine
C20H35NO18S (609.1574770000001)
2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
C20H35NO18S (609.1574770000001)
4-chloro-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
4-chloro-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
4-chloro-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromenium-3-yl 6-O-[(2Z)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranoside
2-[(2S,4aR,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-[(2S,4aS,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-[(2R,4aR,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-[(2R,4aR,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
4-chloro-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
4-chloro-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
4-chloro-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
4-chloro-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc6S
C20H35NO18S (609.1574770000001)
beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc6S
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->3)-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc6S
C20H35NO18S (609.1574770000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1,3-dihydroxy-2-methyl-4-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)butan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[3,4-dihydroxy-3-methyl-1-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)butan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
peonidin 3-O-(6-O-(Z)-4-coumaroyl-beta-D-glucoside)
An anthocyanin cation that is peonidin substituted at position 3 by a 6-O-(cis-4 coumaryl)-beta-D-glucosyl residue.
peonidin 3-O-(6-O-(E)-4-coumaroyl-beta-D-glucoside)
An anthocyanin cation that is peonidin substituted at position 3 by a 6-O-(trans-4 coumaryl)-beta-D-glucosyl residue
SR 146131
SR 146131 is a potent, orally available, and selective nonpeptide (cholecystokinin 1) receptor agonist.
(3s,6r,9s,12s,14e,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-9-(hydroxymethyl)-3,7,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
C28H40BrN3O7 (609.2049470000001)
methyl 2-{1-[9-hydroxy-10-(3-hydroxyquinoline-2-amido)-5-methyl-6-oxo-1,2-dithia-5,8-diazacycloundec-8-en-4-yl]-n-methylformamido}-3-(methylsulfanyl)propanoate
C25H31N5O7S3 (609.1385535999999)
(3s,6r,9r,12s,14e,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-9-(hydroxymethyl)-3,7,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
C28H40BrN3O7 (609.2049470000001)
(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-4-{[(2e)-3-(3h-imidazol-4-yl)prop-2-enoyl]oxy}-5-[(r)-methanesulfinylmethyl]oxolan-3-yl (2z)-3-(4-hydroxyphenyl)-2-methoxyprop-2-enoate
7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2s,3s,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
(3s,6r,9r,12r,14e,16s,18r)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3-(hydroxymethyl)-7,9,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
C28H40BrN3O7 (609.2049470000001)
methyl (2r)-2-{1-[(4r,10s)-9-hydroxy-10-(3-hydroxyquinoline-2-amido)-5-methyl-6-oxo-1,2-dithia-5,8-diazacycloundec-8-en-4-yl]-n-methylformamido}-3-(methylsulfanyl)propanoate
C25H31N5O7S3 (609.1385535999999)
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-{[(2s,3s,4r,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
(3s,6r,9s,12s,14e,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3-(hydroxymethyl)-7,9,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
C28H40BrN3O7 (609.2049470000001)